Holding(s) in Company
Summary by AI BETAClose X
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BYWL4Y04
Issuer Name
RENALYTIX PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Aberdeen Group plc
City of registered office (if applicable)
Edinburgh
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
08-Sep-2026
6. Date on which Issuer notified
09-Sep-2026
7. Total positions of person(s) subject to the notification obligation
|
|
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
Resulting situation on the date on which threshold was crossed or reached |
9.848687 |
0.000000 |
9.848687 |
59,469,395 |
|
Position of previous notification (if applicable) |
Below 5% |
Below 5% |
Below 5% |
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
|
GB00BYWL4Y04 |
|
59,469,395 |
|
9.848687 |
|
Sub Total 8.A |
59,469,395 |
9.848687 | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
|
|
Sub Total 8.B1 |
|
|
| |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
|
|
|
|
|
|
|
|
Sub Total 8.B2 |
|
|
| ||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
|
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
Aberdeen Group plc |
|
|
|
|
|
Aberdeen Group plc |
abrdn Holdings Limited |
|
|
|
|
Aberdeen Group plc |
abrdn Inc. |
9.848687 |
0.000000 |
9.848687 |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
11. Additional Information
In reference to Section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.
This disclosure also reflects the fact that the voting rights effectively held indirectly by the underlying intermediate holding company abrdn Holdings Limited (“aHL”) and held by the underlying investment management entity abrdn Inc. ("aI”) increased above the 5% notifiable threshold due to the participation in the Issuer’s First Tranche Shares of its WRAP Retail Offer on 8th September 2026. aHL now effectively holds and aI holds the delegated voting rights to 9.848687% of the shares in Renalytix PLC.
12. Date of Completion
09-Sep-2026
13. Place Of Completion
Edinburgh, United Kingdom
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago River Global Plc
- 3 hours ago Pipehawk
- 3 hours ago Frasers Group
- 3 hours ago DP Aircraft I Limited Pref
- 3 hours ago Cropper (James)